Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Mcap of 8 most valued firms surges by ₹1.90 trn, ICICI Bank shines
The combined market valuation of eight of the top-10 most valued firms surged by Rs 1.90 lakh crore last week, with ICICI Bank stealing the show, in tandem with a rally in equities. Last week, the BSE benchmark Sensex jumped 1,284.61 points, or 1.73 per cent, and the NSE Nifty surged 256.2 points, or 1 per cent. "Indian equity markets ended a volatile week on a strong note, snapping a two-week losing streak amid improving global sentiment and supportive measures from the Reserve Bank of India (RBI) aimed at attracting foreign currency inflows," Ajit Mishra, SVP, Research, Religare Broking Ltd, said. Investor confidence improved on optimism surrounding a potential USIran peace deal, which raised hopes of easing geopolitical tensions and stabilising energy markets, he added. From the top-10 pack, Reliance Industries, HDFC Bank, Bharti Airtel, ICICI Bank, State Bank of India, Bajaj Finance, Larsen & Toubro and Hindustan Unilever were the winners, while Tata Consultancy Services (TCS)
RBL Bank taps HDFC veteran Bhavin Lakhpatwala as CFO
RBL Bank has appointed Bhavin Lakhpatwala as its new Chief Financial Officer. Lakhpatwala joins from HDFC Bank, bringing over 25 years of finance experience. This appointment fills a vacant position and comes as Emirates NBD moves to acquire a controlling stake. The new CFO is expected to guide the bank through its ownership transition and future growth phase.
India's gold demand picks up, China premiums ease: What is driving the trend
India gold demand rises on price dip as China premiums ease, with cautious buying, ETF outflows, and central bank reserves shaping the global bullion outlook.
Further consolidation ahead for Nifty? Here's today's outlook and top picks
Ajit Mishra of Religare Broking has recommended buying the shares of Fortis Healthcare, RBL Bank, and Eternal today
INR pares initial losses and settles largely unchanged
The Indian rupee was largely flat and settled almost unchanged at Rs 95.43 per dollar, down just 2 paise on Wednesday, amid likely intervention from the Reserve Bank of India (RBI) to curb excessive volatility and prevent a further slide in the domestic unit. Rupee pared its initial losses as crude oil prices and the US dollar index retreated from their elevated levels. Indian shares gave up early gains to end little changed on Wednesday as investors weighed rising U.S.-Iran tensions and awaited key U.S. inflation data later in the day for fresh insights into market expectations for future interest rates in the face of rising energy-driven inflation risks. The BSE Sensex ended the day at 73,983.18, up by 64.42 points (0.09%), while the NSE Nifty 50 settled at 23,214.95, slipping by 27.15 points (-0.12%).
ICICI Prudential Mutual Fund raises stake in Travel Food Services, shares rise
ICICI Prudential Mutual Fund has announced the acquisition of an additional stake in Travel Food Services, increasing its total shareholding in the company to above 5%.
Stocks to Watch today: IndiGo, Afcons, Bharti Hexacom, JSW Infra, NTPC
Stocks to Watch today: IndiGo, SpiceJet, Afcons infra, JSW Infra, Bharti Hexacom, NTPC Green Energy, NTPC, NLC India, FirstCry, JW Steel, HDFC Bank, among others, will in focus today.
Sensex Today | Stock Market LIVE Updates: GIFT Nifty trades lower; Jefferies initiates 'buy' for Meesho
Sensex Today | Stock Market LIVE Updates: The Nifty though, dragged by HDFC Bank and IT on Tuesday, would be hopeful that both put their hand up and enable a breakout for the index as well. A factor that bulls will take heart from is that Reliance Industries snapped a nine-day losing streak on Tuesday and if that rebounds from lower levels, it will be a big boost to the index.
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
SBI in $1 billion funding for Sun Pharma’s US deal
State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co. This move marks a significant step for government-run banks in financing corporate takeovers. SBI will join other global lenders in this substantial deal. The funding underscores the growing ambition of Indian companies to expand globally.
Explained: How AI mania has thrown India Inc out of MSCI EM's top 10 and world's top 100 list
Indian companies are no longer in the top 10 of the MSCI Emerging Markets Index. A surge in AI stocks has shifted global capital. Taiwan and South Korea's chipmakers now dominate the index. Reliance Industries and HDFC Bank have fallen in global rankings. India's market weight has hit a six-year low. This concentration is driven by strong company growth.